Behavioral Monitoring in Primary Care

Status Terminated

Clinical Trial Summary

Stress and anxiety can worsen quality of life in patients seen in primary care practices. Patients at predetermined practices age 20-65 receive psychosocial screening instruments for anxiety and quality of life (GAD7 and SF-12) at six month intervals for twenty-four months as part of routine care. Assessing anxiety and quality of life every six months will provide data to analyze whether anxiety and quality of life changes over time.

Patients who consent will also be asked at 6, 12, 18, and 24 months about medical utilization of behavioral care or any medical care outside of University of Pittsburgh Medical Center in order to be part of their research record for good clinical care. If patients received any behavioral treatment, the patient will also be asked questions regarding the helpfulness of this treatment.

This is an observational characterization study to understand the psychiatric and behavioral needs of primary care patients. The follow-up questionnaires and medical record information will look at the rates and predictors of hospitalizations and/ or behavioral health treatment as a longitudinal way to track these symptoms over time. These resources are critical to determine the need for embedded behavioral care in primary care settings.

Clinical Trial Description

Patients who are receiving or seeking medical care at University of Pittsburgh Medical Center CMI practices are given the GAD7(anxiety) and SF-12(quality of life) as a part of routine medical care. Patient scores become part of the EMR (Epic). A best practice alert will be generated for patients in the age range of 20-65 (inclusive) and in the targeted GAD7 score range (GAD7 ≥5) to prompt the provider to obtain consent. Within 2-4 weeks after consent, a UPMC research team member will administer via phone a brief, approximately 10 minute questionnaire for patients who score ≥10 on the GAD7 questionnaire and have signed consent. This DSM5 cross-cutting measure level 1 is a validated screening tool capturing primary psychiatric symptoms present across a range of disorders. A secure database will be maintained within the UPMC firewall where all patient information will be de-identified. Routine care safety protocols are in place if a patient's anxiety/stress worsens. At 6,12,18, and 24 months post-consent, the research team will contact the patient by phone to complete routine questionnaires (GAD7 and SF-12) if questionnaires have not been completed in clinic at an appointment or via the patient portal, MyUPMC. As part of the study, the patient will complete the Medical Utilization/Follow up questionnaire by phone with the research team at the 6, 12, 18, and 24 month time points. If the patient had any behavioral health treatment the research team will also ask the Helpfulness Questionnaire at the six month time point. In addition to these questionnaires, the research team will access Epic records to understand medical utilization.

CARe will provide the information from the medical record. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03139357
Study type	Observational
Source	University of Pittsburgh
Contact
Status	Terminated
Phase
Start date	December 22, 2016
Completion date	March 7, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03036423` - Cognitive Training for Older Caregivers	N/A
Completed	`NCT01767922` - Multicentre, Double-blind Study Versus Placebo on Impact and Safety of Extramel® 140 IU on Perceived Stress, Physical and Intellectual Fatigue, Pain Perception if Present, and the Impact on the Quality of Life	Phase 3
Completed	`NCT04392869` - The Effects of Mindfulness-based Training in Undergraduate Students of Translation and Interpreting	N/A
Completed	`NCT05598944` - The Effects of Psycho-educational Training in Undergraduate Students at the University of Granada (Spain)	N/A
Completed	`NCT03908190` - Personalized Support for Progress (PSP) in a VA Women's Wellness Clinic	N/A
Completed	`NCT06280261` - The Struggle That Is Phenylketonuria : What Do The Patients and Caregivers Suffer From
Completed	`NCT02755012` - Impact of Maternal Stress on Infant Stunting	N/A
Recruiting	`NCT04900064` - Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial	N/A
Not yet recruiting	`NCT04133753` - Evaluating Effectiveness of a Communication Facilitator : A Randomized Trial	N/A
Recruiting	`NCT05422638` - Race-Based Stress Trauma and Empowerment	N/A
Recruiting	`NCT05335382` - Implementation and Evaluation of Primary Care Behavioral Health in Sweden	N/A
Completed	`NCT05775978` - Psycho-educational Training in Undergraduate Students at the University of Granada (Spain). Second Edition	N/A
Completed	`NCT01488422` - Neural Correlates of Stress Reduction	N/A
Completed	`NCT01997151` - Promoting Health During Pregnancy: A Multiple Behavior Computer Tailored Intervention	N/A
Not yet recruiting	`NCT06341569` - Physical Therapy Students: Well-being	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.